Omni stock

Private-market facts for current and former Omni employees researching their stock.

Latest Round
Series B
Valuation
Not publicly disclosed
Founded
2021
Headquarters
San Francisco, CA
Founders
Colin Zima, Chris Lambert, Jamie Davidson
Status
private
Employees
725 +43% YoY
Total Raised
$69M

Talk to a Omni stock specialist

Get personalized guidance on your Omni shares — including current market activity, pricing context, and liquidity options.

Speak with an expert

Overview

Omni is a business intelligence platform that combines a shared data modeling layer with a modern SQL IDE and visualization tools for analytics teams.

Omni outlook

Equity outlook95% data confidence
1x
Base scenario
3x
Upside scenario

For employees evaluating Omni equity, a 1x base multiple suggests the stock may be close to fairly valued at current prices. The upside scenario at 3x is relatively close to the base case, suggesting more predictable but narrower range of outcomes.

These estimates reflect modeled return scenarios, not guaranteed outcomes. Actual results depend on company performance, market conditions, share class, and timing.

Illustrative model · v1.0.0 · Not investment advice

Selling Omni shares

Why shareholders consider selling

Shareholders in Omni may explore liquidity for a number of reasons — diversifying a concentrated position, funding a personal financial goal, or simply reducing exposure to a single private holding. As a private company, Omni does not trade on a public exchange, meaning employees and early shareholders cannot simply sell through a brokerage. Extended private timelines can leave shareholders waiting years for an exit event, which is why some choose to explore secondary-market options.

Can you sell Omni stock?

Whether a shareholder can sell typically depends on what they hold and how it was acquired. Vested and exercised shares are generally more straightforward than unexercised options or unvested RSUs. Most private companies, including those in the Data & Analytics sector, impose transfer restrictions such as rights of first refusal or board approval requirements. The specific terms governing Omni shares would be outlined in the holder's equity agreement or the company's governing documents.

What affects the value of Omni shares?

The price a buyer is willing to pay for private shares is shaped by several factors: overall demand for the stock, the company's financial performance, broader Data & Analytics market conditions, and any recent private-market transaction activity. Data points such as the company's Series B round can help frame expectations, though they do not guarantee a transaction price.

What should holders check before selling

Tools for Omni shareholders

Exploring equity in Omni often raises questions about taxes, exercise timing, valuation, and exit outcomes. These tools can help you model different decisions using your own assumptions.

Latest funding round

Omni most recently raised a Series B round . Total funding raised to date is approximately $69M.

Omni funding history

Seed Round 2022
$9M
Series A 2022
$18M
Series B 2025
$69M
Series C 2026
$120M
Date Round Amount Lead investors
Apr 2026 Series C $120M
Mar 2025 Series B $69M
Aug 2022 Series A $18M
Apr 2022 Seed Round $9M

Omni IPO & exit outlook

Omni has not announced a confirmed IPO date or acquisition. At the Series B stage, most companies are still years away from a public listing or acquisition.

For employees holding equity, the timeline to liquidity is uncertain. Options to consider include:

Read our liquidity guide for a full comparison of paths to liquidity.

Founders & company background

Omni was founded in 2021 by Colin Zima, Chris Lambert, Jamie Davidson and is headquartered in San Francisco, CA.

Industry

Similar private companies

Latest Omni news

Banking sector key to realising Viksit Bharat vision: SBI Chairman C S Setty
Banking sector key to realising Viksit Bharat vision: SBI Chairman C S Setty
SBI is set to play a key role in India's growth. The bank is focusing on a 'Digital First, Customer First' strategy. Investments in technology, data, and AI will create a responsive banking ecosystem. SBI aims to deliver personalized experiences across all channels. Physical branches will integrate with digital platforms for an omni-channel approach.
The Economic TimesMay 27, 2026
The World’s #1 Bestselling Robotic Window Cleaner: ECOVACS WINBOT Restores Crystal-Clear Views with Ease
The World’s #1 Bestselling Robotic Window Cleaner: ECOVACS WINBOT Restores Crystal-Clear Views with Ease
SINGAPORE - Media OutReach Newswire - 19 May 2026 - The ECOVACS WINBOT is the world's #1 bestselling robotic window cleaner, according to data from global market intelligence firm IDC. ECOVACS Robotics, a global leader in service robotics, pioneered this category in 2011 with the WINBOT 5 Series - the world's first robotic window cleaner. ECOVACS' 'Created for Ease' philosophy led it to create the WINBOT to bring consumers a smarter, safer, and easier way to tackle window cleaning.**media[1062319]** Keeping the large windows and expansive views in today's modern homes crystal-clear can be risky, inconvenient, and labor-intensive. Windows are constantly exposed to dust, pollution, and severe weather. For those in high-rise buildings, cleaning exterior windows can be dangerous and requires expensive professional help. Manual cleaning often leaves streaks. Scrubbing large glass surfaces can be tiring. These challenges lead many to avoid cleaning their windows altogether. Robotic window cleaners like the ECOVACS WINBOT help solve these pain points so users can enjoy clear views from edge to edge with ease. Consumer demand for them is surging, according to IDC, which found that the ECOVACS WINBOT was the world's #1 selling robotic window cleaner in 2025.1 It has also been #1 in China for three consecutive years according to data from All View Cloud (AVC).A Trusted Choice for Effortless Cleaning ECOVACS is a pioneer in service robotics. Knowing that consumers want effortless smart home cleaning solutions beyond floor cleaning, it began developing robotic window cleaners 15 years ago. Since the first WINBOT, the line has undergone seven generations of core upgrades. Leveraging its R&D strengths, ECOVACS continually sets new industry benchmarks with innovative technologies that make window cleaning safer, faster and more convenient for users. ECOVACS WINBOT's innovations for enhanced cleaning performance are designed to effectively remove dust, rain stains, and pollution buildup. For example, ECOVACS' TruEdge Technology is designed to clean edges and hard-to-reach corners - ensuring spotless, crystal-clear views - and its Three-nozzle Wide-angle Spray Technology enables a deeper clean. Other innovations enhance convenience. The all-in-one OMNI Station is a control panel, charger, stabilizer, and portable storage space for the WINBOT and its accessories. It is also equipped with a safety rope with a tensile strength of up to 100KG. Other WINBOT safety features include optimized suction power, anti-drop protection, edge detection, smart navigation for obstacle avoidance, and insurance protection. The ECOVACS WINBOT's sales performance is also impressive. In 2025, its sales volume exceeded 1 million units, with cumulative global sales surpassing 2.6 million units. From entry-level to premium models, ECOVACS offers a diverse WINBOT product portfolio across different markets to meet users' needs for taking care of various glass surfaces, including glass panels, balcony glass, and shower screens. The ECOVACS WINBOT family revolutionizes window cleaning with cutting-edge technologies that bring users a high-performance, convenient and hassle-free experience that ensures crystal-clear views with absolute peace-of-mind.
The Manila TimesMay 19, 2026
Sight Sciences’ Interventional Technologies for Glaucoma and Dry Eye Disease to be Featured in Multiple Clinical Presentations at the 2026 American Society of Cataract and Refractive Surgery (ASCRS) A
Sight Sciences’ Interventional Technologies for Glaucoma and Dry Eye Disease to be Featured in Multiple Clinical Presentations at the 2026 American Society of Cataract and Refractive Surgery (ASCRS) A
MENLO PARK, Calif., April 01, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences, or the Company), an eyecare company focused on developing and commercializing innovative, interventional technologies intended to transform care and improve patients’ lives, today announced that data on two of its proprietary glaucoma and dry eye technologies, the OMNI® Surgical System and the TearCare® System, will be presented at this year’s ASCRS Annual Meeting held in Washington, DC.
The Manila TimesApr 1, 2026

Talk to a Omni stock specialist

Get personalized guidance on your Omni shares — including current market activity, pricing context, and liquidity options.

Speak with an expert

Frequently asked questions

Is Omni a public or private company?
Omni is a private company as of the most recent data available. Its shares do not trade on a public stock exchange. Employees and early shareholders who want liquidity may need to explore secondary-market options or wait for a future IPO or acquisition.
What is Omni's valuation?
Omni's valuation has not been publicly disclosed. Private company valuations are typically set during funding rounds and are not always reported publicly.
What is Omni's stock price per share?
Omni does not trade on a public exchange, so there is no single live stock price. Indicative pricing may be available through secondary-market platforms. The most recent known valuation data can help frame expectations, but common shares typically trade at a discount to the headline preferred-stock valuation.
When will Omni IPO?
Omni has not announced a confirmed IPO date. IPO timing depends on market conditions, company financials, and board decisions. Employees should plan around the possibility that liquidity may take years and consider whether secondary-market options or company-sponsored tender offers are available in the interim.
Can I sell my Omni stock?
It depends on what you hold and your company's policies. Vested, exercised shares are generally eligible for secondary-market sales, subject to Omni's transfer restrictions and right of first refusal (ROFR). Unexercised options and unvested RSUs typically cannot be sold. Some companies also run periodic tender offers that allow employees to sell a portion of their holdings at a set price. Check your equity agreement or speak with your stock plan administrator for Omni-specific rules.
How much does it cost to exercise Omni stock options?
The out-of-pocket cost equals your strike price multiplied by the number of shares you exercise. For ISOs, exercising may also trigger the Alternative Minimum Tax (AMT) based on the spread between your strike price and the current fair market value. For NSOs, the spread is taxed as ordinary income at exercise. Use our AMT Calculator and Stock Option Tax Calculator to model the cost for your specific situation.
What type of stock options does Omni grant — ISOs or NSOs?
Most venture-backed companies grant ISOs (Incentive Stock Options) to U.S. employees where possible, with NSOs (Non-Qualified Stock Options) used for amounts exceeding the $100K annual ISO limit, for contractors, or for non-U.S. employees. Your specific grant type is listed in your option agreement. The distinction matters because ISOs can qualify for long-term capital gains treatment, while NSOs are taxed as ordinary income at exercise. See our ISO guide and NSO guide for the full breakdown.
What happens to my Omni stock if the company is acquired?
In an acquisition, your equity outcome depends on the deal structure and your grant terms. Common scenarios include cash-out (your shares are bought at a set price per share), rollover (your shares convert into the acquirer's equity), or cancellation with an acceleration clause. If you have double-trigger acceleration, your unvested shares may accelerate only if you are also terminated. The liquidation preference stack determines how proceeds are divided — preferred shareholders are paid first, which can reduce or eliminate the payout to common shareholders in lower-value exits.
What is the difference between common and preferred Omni stock?
Employees typically hold common stock (or options on common stock). Investors hold preferred stock, which usually comes with a liquidation preference — meaning investors get paid first in an exit before common shareholders receive anything. This distinction is critical when estimating what your shares might actually be worth in an exit.
What happens to my Omni options if I leave?
When you leave a company, you typically have a limited post-termination exercise window — often 90 days — to exercise your vested options or they expire worthless. Some companies offer extended windows (up to 10 years). Unvested options are forfeited. If you hold ISOs and don't exercise within 90 days of leaving, they convert to NSOs, which changes the tax treatment. Review your option agreement for Omni's specific terms, and use our Exercise Timing Planner to model the financial tradeoffs.

Related pages

Last verified: 2026-05-28 · Omni data compiled from funding disclosures, corporate filings, and public records.

Information on this page is compiled from publicly available sources and may be outdated or incomplete. This is not investment advice. Consult a qualified advisor before making financial decisions.